The U.S. Food and Drug Administration (FDA) warned restaurants and retailers in nine states[2] to stop selling raw oysters, clams, and shellstock from Washington’s Gomez Shellfish because of possible norovirus.
The advisory matters because norovirus can cause severe vomiting and diarrhea, leading to hospital visits and outbreaks that spread quickly through the food‑service chain.
The recalled shellstock was harvested between March 22 and April 9, 2024, according to the FDA’s own briefing[1]. A separate report from KOIN listed an earlier window of February 13 through March 3, 2024[4], highlighting a discrepancy in the harvest dates.
Washington State’s Department of Health issued a recall on April 10, 2024[1]. The FDA’s safety alert was reported by WWAYTV3 as being released on March 9, 2024[3], a date that differs from the Fast Company timeline linking the warning to the April 10 recall.
The FDA’s notice covered distributors in at least nine states, including California, Washington, Oregon, Arizona, Florida, Georgia, and New York[2]. Retailers in these markets were instructed to remove the products from menus and shelves immediately.
Businesses are advised to stop serving the affected shellstock, discard any inventory and notify customers of the recall. Consumers who may have purchased the items should discard them or return them for a refund.
Public‑health officials will continue testing the remaining stock and monitor for any reported illnesses, while the FDA evaluates whether additional actions are needed to protect consumers.
“The FDA warned restaurants and retailers in nine states to stop selling raw oysters, clams and shellstock from Washington’s Gomez Shellfish because of possible norovirus.”
The warning underscores how quickly a potential norovirus contamination can trigger nationwide recalls, prompting restaurants and retailers to act swiftly to prevent food‑borne illness and protect public health.
